PROTEROS biostructures GmbH
Edit

PROTEROS biostructures GmbH

http://www.proteros.com/
Tags:BioTechDevelopmentDrugFinTechHealthTechInformationMedtechProviderResearchService
Proteros is a privately held early-stage services provider in structure-based drug discovery with a cutting-edge discovery engine tailored to unlock even the most technically challenging targets. Proteros’ work is built on scientific excellence and supports its clients to reach the right results and accelerate their overall research timelines. Proteros supports most of the world’s 20 largest pharma companies and more than 250 pharmaceutical and biotech partners in the US, Europe and Japan. For more information please visit www.proteros.com. As we continue to grow, we constantly look for committed, professional and energetic people with a high sense of responsibility, who enjoy challenges. We provide the environment for your career development and the tools you need to reach ambitious goals whilst striving for the highest standards of professional excellence. Join the Proteros team! http://www.proteros.de/company/career/ Proteros assumes no responsibilities of whatsoever nature for the suitability of the information contained herein for the customer. All references to offers for services, including research services, crystallography services, protein supply, cryo-EM and screening services are subject to a formal offer and contract to be agreed upon by Proteros and the customer. The conditions of such contract will be set forth in the respective order process.
Location: Germany, Bavaria, Martinsried
Member count: 51-200
Founded date: 2000

Investors 1

DateNameWebsite
09.03.2023Inflexion ...inflexion....

Mentions in press and media 7

DateTitleDescriptionCategoryAuthorSource
09.01.2023Proteros R...Proteros biostructures GmbH, a...Germany-finsmes.co...
25.10.2022Proteros a...Proteros selected by Adrestia ...--einpresswi...
25.10.2022Proteros a...Proteros selected by Adrestia ...--globenewsw...
08.09.2020Proteros l... MUNICH, Sept. 8, 2020 /PRNew...--prnewswire...
29.05.2014Rodin Ther...Rodin Therapeutics, Inc., a Ca...funding S...-finsmes.co...
27.06.2013J&J an...Rodin Therapeutics has access ...--medcitynew...
-J&J an...Johnson & Johnson (NYSE: J...--medcitynew...